This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Aortic Valve

July 27, 2023
In forty-eight consecutive patients undergoing explants of transcatheter aortic valve replacement (TAVR) at a single center between 2011 and 2021, at a median of 2.3 years after TAVR, the most common indications for surgery were nonstructural valve dysfunction (patient-prosthesis mismatch or paravalvular leak) in 35 percent, structural valve deterior
June 29, 2023
Recently, a minimal approach to transcatheter valve replacement using only local anesthesia has been used to promote a faster procedure and recovery time. With this lack of general anesthesia, however, comes more anxiety and the possibility of pain for patients.
June 29, 2023
Transcatheter aortic valve implantation (TAVI) is now a standard procedure for the treatment of symptomatic aortic valve stenosis in many patients.
May 25, 2023
A study found that patients who underwent a second TAVR procedure were no more likely to experience adverse outcomes than those who have only undergone one TAVR.
May 4, 2023
A forty-six-year-old male with a history of bicuspid aortic valve and failed previous transcatheter aortic valve replacement for symptomatic aortic stenosis underwent surgical explantation of the failed transcatheter aortic valve followed by the Ross procedure using a pulmonary autograft-in-conduit technique with a 30 mm Gelweave graft and reconstruction with a 29 mm pulmonary homograft.
April 13, 2023
Models created using artificial intelligence can now be used to help identify patients who may need a permanent pacemaker after transcatheter valve surgery.
April 6, 2023
In the first analysis to validate observed clinical outcomes, two trials compared transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (AVR). Valve dysfunction was found to be less common after five years in TAVR.
February 9, 2023
A retrospective analysis of early experience with a new approach to totally endoscopic aortic valve replacement in 266 patients showed satisfactory results, with acceptable morbidity and low mortality rates.